Frédérick A. Mallette

Author

Also Known As

F. Mallette, F.A. Mallette, Frederick A. Mallette, Frederick Antoine Mallette, Frederick Mallette, Frédérick A. Mallette, Frédérick A Mallette, Frédérick A. Mallette, Frédérick Antoine Mallette, Frédérick Mallette

101

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Université de Montréal Hôpital Maisonneuve-Rosemont McGill University Jewish General Hospital Université Laval

About

Frédérick A. Mallette is an author at Université de Montréal specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	19	2.2K
2	Cell Biology	16	17	2.1K
3	Natural Sciences	4	4	205
4	Health Sciences	1	1	90
5	Cellular Physiology	1	1	23

Frédérick A. Mallette

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
mTOR as a central regulator of lifespan and aging David Papadopoli, Karine Boulay, Lawrence Kazak, F1000Research	2019	419
The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence Frédérick A. Mallette, Marie‐France Gaumont‐Leclerc, Gerardo Ferbeyre Genes & Development Dna DamageGeneticsApoptosisP53 AccumulationCell Death	2007	397
RNF8‐ and RNF168‐dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites Frédérick A. Mallette, Francesca Mattiroli, Gaofeng Cui, The EMBO Journal	2012	344
Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy François Binet, Gaël Cagnone, Sergio Crespo‐Garcia, Science Ocular DiseaseImmunologyRetinal TherapiesOcular Surface PhysiologyInflammation	2020	272
Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy Malika Oubaha, Khalil Miloudi, Agnieszka Dejda, Science Translational Medicine	2016	253
DNA Damage Signaling and p53-dependent Senescence after Prolonged β-Interferon Stimulation Olga Moiseeva, Frédérick A. Mallette, Utpal K. Mukhopadhyay, Molecular Biology of the Cell Dna DamageImmunologyCell DeathP53 ActivityOxidative Stress	2006	239
Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation Xavier Deschênes‐Simard, Marie‐France Gaumont‐Leclerc, Véronique Bourdeau, Genes & Development	2013	188
The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway Mélissa Carbonneau, Laurence M. Gagné, Marie‐Eve Lalonde, Nature Communications	2016	176
Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition Sergio Crespo‐Garcia, Pamela R. Tsuruda, Agnieszka Dejda, Cell Metabolism Ocular DiseaseAngiogenesisOphthalmologyPathological AngiogenesisBcl-xl Inhibition	2021	173
Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma Yong Yu, Kolja Schleich, Bin Yue, Cancer Cell PhotocarcinogenesisMelanomaMolecular BiologyCellular SenescenceTumor Suppressor	2018	156

Page 1